Prigent, F.-V.; Guillen, K.; Comby, P.-O.; Pellegrinelli, J.; Falvo, N.; Midulla, M.; Majbri, N.; Chevallier, O.; Loffroy, R.
Selective Arterial Embolization of Renal Angiomyolipomas with a N-Butyl Cyanoacrylate-Lipiodol Mixture: Efficacy, Safety, Short- and Mid-Term Outcomes. J. Clin. Med. 2021, 10, 4062.
https://doi.org/10.3390/jcm10184062
AMA Style
Prigent F-V, Guillen K, Comby P-O, Pellegrinelli J, Falvo N, Midulla M, Majbri N, Chevallier O, Loffroy R.
Selective Arterial Embolization of Renal Angiomyolipomas with a N-Butyl Cyanoacrylate-Lipiodol Mixture: Efficacy, Safety, Short- and Mid-Term Outcomes. Journal of Clinical Medicine. 2021; 10(18):4062.
https://doi.org/10.3390/jcm10184062
Chicago/Turabian Style
Prigent, François-Victor, Kévin Guillen, Pierre-Olivier Comby, Julie Pellegrinelli, Nicolas Falvo, Marco Midulla, Nabil Majbri, Olivier Chevallier, and Romaric Loffroy.
2021. "Selective Arterial Embolization of Renal Angiomyolipomas with a N-Butyl Cyanoacrylate-Lipiodol Mixture: Efficacy, Safety, Short- and Mid-Term Outcomes" Journal of Clinical Medicine 10, no. 18: 4062.
https://doi.org/10.3390/jcm10184062
APA Style
Prigent, F.-V., Guillen, K., Comby, P.-O., Pellegrinelli, J., Falvo, N., Midulla, M., Majbri, N., Chevallier, O., & Loffroy, R.
(2021). Selective Arterial Embolization of Renal Angiomyolipomas with a N-Butyl Cyanoacrylate-Lipiodol Mixture: Efficacy, Safety, Short- and Mid-Term Outcomes. Journal of Clinical Medicine, 10(18), 4062.
https://doi.org/10.3390/jcm10184062